TNDM earnings

Tandem Diabetes (TNDM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

TNDM earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 5, 2026-0.10-0.2559.24%$283.69M
Q2 2026Aug 6, 2026-0.31-0.323.35%$254.56M
Q1 2026May 7, 2026-0.30-0.4634.78%$247.22M
Q4 2025Feb 19, 2026-0.01-0.0580.00%$290.38M
Q3 2025Nov 6, 2025-0.31-0.310.00%$249.25M
Q2 2025Aug 6, 2025-0.48-0.40-20.00%$240.68M
Q1 2025Apr 30, 2025-0.67-0.60-11.67%$234.42M
Q4 2024Feb 26, 20250.01-0.23104.35%$282.65M
Q3 2024Nov 6, 2024-0.35-0.4012.50%$243.97M
Q2 2024Aug 1, 2024-0.48-0.5411.11%$221.91M
Q1 2024May 2, 2024-0.63-0.7617.11%$191.67M
Q4 2023Feb 21, 2024-0.27-0.25-8.00%$196.80M
Q3 2023Nov 1, 2023-0.38-0.34-11.76%$185.62M
Q2 2023Aug 3, 2023-0.55-0.54-1.85%$195.92M
Q1 2023May 3, 2023-1.92-0.56-242.86%$169.38M
Q4 2022Feb 22, 2023-0.01-0.0250.00%$220.50M
Q3 2022Nov 2, 2022-0.76-0.05-1420.00%$204.55M